CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Grant or award Chief Marketing Officer acquired 150,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at $2.14 ($106,800)
- 4 Open-market buy General Counsel & CCO bought 5,000 shares at $3.14 ($15,700)
- 4 Open-market buy Director bought 2,000 shares at $3.28 ($6,560)
- 4 Gift Chief Acquisition Officer gave 60,000 shares (gift)
- 4 Gift CEO gave 60,000 shares (gift)
- 4 Option exercise President acquired 22,000 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Principal Accounting Officer acquired 5,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise General Counsel & CCO acquired 12,500 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 25,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 6 of 12 · 230 filings